How Moderna’s people strategy helped bring the COVID vaccine to market

This is a preview. View original post on this site

Two years ago, few people outside of biopharmaceutical circles had likely heard of the company Moderna. Now, it’s a household name—thanks to its COVID-19 vaccine, which received emergency use authorization by the U.S. Food & Drug Administration at the end of 2020. As of last week, more than 156 million Moderna COVID vaccines have been administered in the U.S.

With demand like that, Moderna had to rely on its people like never before—and scale up quickly. When CHRO Tracey Franklin joined the organization in October 2019, less than six months before the pandemic started, the company employed just 800 people. Today,

Read Complete Article

,

Subscribe to Recruiting Headlines

* indicates required


RECRUITMENT MARKETPLACE


»Need an ATS? Try JazzHR


»Free Rejection Email Templates


»Text Recruiting Software


»RecTech Live Webcasts


»HR Podcast Directory


»Recruiting Newsletters


»HR Tech News


»Freelance HR Jobs


»Diversity Hiring News


»Recruiter Ebooks